Page 113
TEAMKY Demonstration
Approval Period: January 1, 2025 through December 31, 2029
Page 112 of 155 Evaluation Question 3: Did rates of opioid-related overdose deaths decrease? Demonstrated Goal: Reduction in opioid-related overdose deaths. Evaluation Hypothesis: The demonstration will decrease the rate of overdose deaths due to opioids.
Primary Driver (Increase the utilization of SUD treatment services at IMD facilities)
Primary Driver (Increase the utilization of SUD treatment services, overall and specifically MAT including methadone)
Use of opioids at high dosage in persons without cancer* NQF #2940 Number of beneficiaries with opioid prescription claims for a morphine equivalent dose of greater than 120 mg for 90 consecutive days Number of beneficiaries with 2+ prescription claims for opioids filled on at least 2 separate dates, for which the sum of days' supply ≥ 15
Claims data
Descriptive statistics
Interrupted time series without comparison group Rate of overdose deaths, specifically overdose deaths due to any opioid* N/A Number of overdose deaths Number of beneficiaries Claims data
Administrative data [vital statistics] Descriptive statistics
Interrupted time series without comparison group Rate of overdose deaths, specifically overdose deaths due to any opioid
Number of overdose deaths, by county Number of beneficiaries Claims data
Administrative data [vital statistics]
Descriptive statistics